These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17276500)

  • 21. Down-regulation of PIK3CG, a catalytic subunit of phosphatidylinositol 3-OH kinase, by CpG hypermethylation in human colorectal carcinoma.
    Semba S; Itoh N; Ito M; Youssef EM; Harada M; Moriya T; Kimura W; Yamakawa M
    Clin Cancer Res; 2002 Dec; 8(12):3824-31. PubMed ID: 12473596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival.
    Barton CA; Gloss BS; Qu W; Statham AL; Hacker NF; Sutherland RL; Clark SJ; O'Brien PM
    Br J Cancer; 2010 Jan; 102(1):87-96. PubMed ID: 19935792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demethylation of the MCJ gene in stage III/IV epithelial ovarian cancer and response to chemotherapy.
    Strathdee G; Vass JK; Oien KA; Siddiqui N; Curto-Garcia J; Brown R
    Gynecol Oncol; 2005 Jun; 97(3):898-903. PubMed ID: 15894365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic regulation of maspin expression in human ovarian carcinoma cells.
    Rose SL; Fitzgerald MP; White NO; Hitchler MJ; Futscher BW; De Geest K; Domann FE
    Gynecol Oncol; 2006 Aug; 102(2):319-24. PubMed ID: 16457875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss.
    Cunningham SC; Gallmeier E; Hucl T; Dezentje DA; Calhoun ES; Falco G; Abdelmohsen K; Gorospe M; Kern SE
    Cancer Res; 2006 Jun; 66(11):5560-4. PubMed ID: 16740690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer.
    Kikuchi R; Tsuda H; Kozaki K; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
    Cancer Res; 2008 Jul; 68(13):5067-75. PubMed ID: 18593905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No evidence exists for methylation inactivation of the p16 tumor suppressor gene in ovarian carcinogenesis.
    Ryan A; Al-Jehani RM; Mulligan KT; Jacobs IJ
    Gynecol Oncol; 1998 Jan; 68(1):14-7. PubMed ID: 9454653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene.
    Su GH; Hilgers W; Shekher MC; Tang DJ; Yeo CJ; Hruban RH; Kern SE
    Cancer Res; 1998 Jun; 58(11):2339-42. PubMed ID: 9622070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.
    Baldwin RL; Nemeth E; Tran H; Shvartsman H; Cass I; Narod S; Karlan BY
    Cancer Res; 2000 Oct; 60(19):5329-33. PubMed ID: 11034065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and mutation analyses of MKK4, a candidate tumour suppressor gene encoded by chromosome 17p, in human gastric adenocarcinoma.
    Chae KS; Ryu BK; Lee MG; Byun DS; Chi SG
    Eur J Cancer; 2002 Oct; 38(15):2048-57. PubMed ID: 12376211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W; Gao N; Shen Y; Cen JN
    J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.
    Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G
    Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fez1/lzts1 alterations in gastric carcinoma.
    Vecchione A; Ishii H; Shiao YH; Trapasso F; Rugge M; Tamburrino JF; Murakumo Y; Alder H; Croce CM; Baffa R
    Clin Cancer Res; 2001 Jun; 7(6):1546-52. PubMed ID: 11410489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RUNX3 gene methylation in epithelial ovarian cancer tissues and ovarian cancer cell lines.
    Zhang S; Wei L; Zhang A; Zhang L; Yu H
    OMICS; 2009 Aug; 13(4):307-11. PubMed ID: 19645591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer.
    Kwong J; Lee JY; Wong KK; Zhou X; Wong DT; Lo KW; Welch WR; Berkowitz RS; Mok SC
    Neoplasia; 2006 Apr; 8(4):268-78. PubMed ID: 16756719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Theoretical proposal: allele dosage of MAP2K4/MKK4 could rationalize frequent 17p loss in diverse human cancers.
    Cunningham SC; Gallmeier E; Hucl T; Dezentje DA; Abdelmohsen K; Gorospe M; Kern SE
    Cell Cycle; 2006 May; 5(10):1090-3. PubMed ID: 16721048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosomal deletion, promoter hypermethylation and downregulation of FYN in prostate cancer.
    Sørensen KD; Borre M; Ørntoft TF; Dyrskjøt L; Tørring N
    Int J Cancer; 2008 Feb; 122(3):509-19. PubMed ID: 17943724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization.
    Shridhar V; Sen A; Chien J; Staub J; Avula R; Kovats S; Lee J; Lillie J; Smith DI
    Cancer Res; 2002 Jan; 62(1):262-70. PubMed ID: 11782386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma.
    Huang J; Zhang YL; Teng XM; Lin Y; Zheng DL; Yang PY; Han ZG
    BMC Cancer; 2007 Jul; 7():126. PubMed ID: 17626620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microvessel density and CpG island methylation of the THBS2 gene in malignant ovarian tumors.
    Czekierdowski A; Czekierdowska S; Danilos J; Czuba B; Sodowski K; Sodowska H; Szymanski M; Kotarski J
    J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():53-65. PubMed ID: 18955754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.